Equibles does not estimate personal net worth.
Get an email with a short summary when GeneDx Holdings Corp. publishes a filing, an earnings call transcript or a press release.
Get WGS alertsGeneDx Holdings Corp. reported in an 8-K filed June 16, 2026 that Mark Gardner was appointed President, effective June 15, 2026. Mark Gardner has spoken on 2 earnings calls across 1 company, most recently for GeneDx Holdings Corp. on November 9, 2026. GeneDx Holdings Corp. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GeneDx Holdings Corp. includes Eric Schadt (CEO and Board Member), Katherine Stueland (CEO and Board Member), Kevin Feeley (CFO) and 7 others.
“On June 16, 2026, GeneDx Holdings Corp. (the "Company") announced the appointment of Mark Gardner, age 60, in the role of President, which was effective on June 15, 2026.”
“Our remarks today will focus on collections and commercial execution. A genetic test that ends the diagnostic odyssey has real value, and we are intent on getting paid for the value we deliver.”
“I'm excited to be here and really grateful for the opportunity to serve patients and customers in this critical segment of the advanced diagnostics industry. You know, I joined GNDX because I saw a company with proven clinical leadership, a strong market position, and a tremendous opportunity ahead.”
SEC 8-K
2026-06-15–present
Diagnostics & Research · Healthcare
